PASG שולי הרווח הגולמי passagebio.com

Passage Bio, Inc. (PASG) focuses on developing gene therapies for rare CNS pathologies. Process sustainability is ensured through resource optimization and strict bioethical standards, while robotic dosing systems enhance research precision. The gross margin ratio clearly demonstrates the business's operational efficiency, while the 0.00 level captures the latest values of this financial indicator.
פילוחי מדדים פיננסיים ומדדי שוק עבור Passage Bio Corp (PASG)

Gross margin reflects the share of profit after deducting direct production costs, allowing investors to assess the operational efficiency of value creation. Analyzing the gross profitability metric is critical for Passage Bio, Inc. (PASG), as it demonstrates the company's ability to control costs amid a high burn rate and the risks associated with gene therapy development, thereby confirming the sustainability of its financial runway.